OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma
Chengpeng Gui, Jinhuan Wei, Yuhang Chen, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Closed Access | Times Cited: 45
Chengpeng Gui, Jinhuan Wei, Yuhang Chen, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Closed Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Peijie Zheng, Chuntao Zhou, Liuyi Lu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 171
Peijie Zheng, Chuntao Zhou, Liuyi Lu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 171
Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma
Chenjie Qiu, Wenxiang Shi, Huili Wu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
Chenjie Qiu, Wenxiang Shi, Huili Wu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
Yue Hou, Sijing Qiao, Miao Li, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 19
Yue Hou, Sijing Qiao, Miao Li, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 19
PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma
Guannan Shu, Minyu Chen, Wuyuan Liao, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1659-1679
Open Access | Times Cited: 5
Guannan Shu, Minyu Chen, Wuyuan Liao, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1659-1679
Open Access | Times Cited: 5
Development of a novel hypoxia-immune–related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer
Likun Luan, Youguo Dai, Tao Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Likun Luan, Youguo Dai, Tao Shen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma
Yi Wang, Xinde Zheng, Gui‐Qi Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Yi Wang, Xinde Zheng, Gui‐Qi Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Integrative analysis of LAG3 immune signature and identification of a LAG3-related genes prognostic signature in kidney renal clear cell carcinoma
Jie Li, Chungan Liu, Hui Su, et al.
Aging (2024)
Open Access | Times Cited: 2
Jie Li, Chungan Liu, Hui Su, et al.
Aging (2024)
Open Access | Times Cited: 2
Integrated analysis of histone modification features in clear cell renal cancer for risk stratification and therapeutic prediction
Wenming Ma, Qintao Ge, Yu Guan, et al.
Translational Oncology (2024) Vol. 47, pp. 102042-102042
Open Access | Times Cited: 2
Wenming Ma, Qintao Ge, Yu Guan, et al.
Translational Oncology (2024) Vol. 47, pp. 102042-102042
Open Access | Times Cited: 2
TAF1D promotes tumorigenesis and metastasis by activating PI3K/AKT/mTOR signaling in clear cell renal cell carcinoma
Xuan Hu, Liang Chen, Tao Liu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111425-111425
Open Access | Times Cited: 2
Xuan Hu, Liang Chen, Tao Liu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111425-111425
Open Access | Times Cited: 2
Deciphering the immune heterogeneity dominated by natural killer cells with prognostic and therapeutic implications in hepatocellular carcinoma
Chengbin Guo, Yuqin Tang, Qizhuo Li, et al.
Computers in Biology and Medicine (2023) Vol. 158, pp. 106872-106872
Closed Access | Times Cited: 6
Chengbin Guo, Yuqin Tang, Qizhuo Li, et al.
Computers in Biology and Medicine (2023) Vol. 158, pp. 106872-106872
Closed Access | Times Cited: 6
CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types
Xinlong Zheng, Kan Jiang, Weijin Xiao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Xinlong Zheng, Kan Jiang, Weijin Xiao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Construction of a hypoxia-immune-related prognostic model and targeted therapeutic strategies for cervical cancer
Shuqian Xie, Bo Ding, Shiyuan Wang, et al.
International Immunology (2022) Vol. 34, Iss. 7, pp. 379-394
Closed Access | Times Cited: 9
Shuqian Xie, Bo Ding, Shiyuan Wang, et al.
International Immunology (2022) Vol. 34, Iss. 7, pp. 379-394
Closed Access | Times Cited: 9
Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma
Wenshuo Zhang, Pang Lyu, Darja Andreev, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Wenshuo Zhang, Pang Lyu, Darja Andreev, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Identification of exosomes-related lncRNAs in clear cell renal cell carcinoma based on Bayesian spike-and-slab lasso approach
Yali Niu, Xiaocan Jia, Nana Wang, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 1
Closed Access | Times Cited: 5
Yali Niu, Xiaocan Jia, Nana Wang, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 1
Closed Access | Times Cited: 5
A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
Juan Zhang, Mi Zhang, Qi Tian, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3867-3881
Open Access | Times Cited: 5
Juan Zhang, Mi Zhang, Qi Tian, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3867-3881
Open Access | Times Cited: 5
Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis
Youwei Yue, Xinyi Cai, Changhao Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Youwei Yue, Xinyi Cai, Changhao Lu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Prognostic value and immune landscapes of anoikis-associated lncRNAs in lung adenocarcinoma
Bo Wu, Xiang Zhang, Nan Feng, et al.
Aging (2024)
Open Access | Times Cited: 1
Bo Wu, Xiang Zhang, Nan Feng, et al.
Aging (2024)
Open Access | Times Cited: 1
Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis
Shuai Wang, Xiyi Wei, Chengjian Ji, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Shuai Wang, Xiyi Wei, Chengjian Ji, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Lipid metabolism-related gene expression in the immune microenvironment predicts prognostic outcomes in renal cell carcinoma
Qian Zhang, Bing-Biao Lin, Huikun Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Qian Zhang, Bing-Biao Lin, Huikun Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Construction of a Prognostic Model for Predicting Colorectal Cancer Prognosis and Response to Immunotherapy Based on Cuproptosis-Associated lncRNAs
Yi Yang, Xiaoli Wang, Jin Lü, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 3
Yi Yang, Xiaoli Wang, Jin Lü, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-16
Open Access | Times Cited: 3
Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma
Qinfan Yao, Xiuyuan Zhang, Chunchun Wei, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17224-e17224
Open Access | Times Cited: 3
Qinfan Yao, Xiuyuan Zhang, Chunchun Wei, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17224-e17224
Open Access | Times Cited: 3
Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma
Maoshu Zhu, Yongsheng Li, Yun Wang, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Maoshu Zhu, Yongsheng Li, Yun Wang, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis
Peizhi Zhang, Jiayi Li, Zicheng Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Peizhi Zhang, Jiayi Li, Zicheng Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
A new approach: Evaluation of necroptosis and immune status enables prediction of the tumor microenvironment and treatment targets in pancreatic cancer
Siyuan Lu, Jie Hua, Jiang Liu, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2419-2433
Open Access | Times Cited: 2
Siyuan Lu, Jie Hua, Jiang Liu, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2419-2433
Open Access | Times Cited: 2
P2RY13 is a prognostic biomarker and associated with immune infiltrates in renal clear cell carcinoma: A comprehensive bioinformatic study
Jie Chu, Wei Liu, Xinyue Hu, et al.
Health Science Reports (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 2
Jie Chu, Wei Liu, Xinyue Hu, et al.
Health Science Reports (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 2
